Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent

Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC patients is still unsatisfactory; one of the reasons for this is the high frequency of recurrence after radical treatment. Consequently, to improve prognosis, it will be impor...

Full description

Bibliographic Details
Main Authors: Munechika Enjoji, Daisuke Watase, Kazuhisa Matsunaga, Mariko Kusuda, Nami Nagata-Akaho, Yoshiharu Karube, Jiro Takata
Format: Article
Language:English
Published: MDPI AG 2015-07-01
Series:Diseases
Subjects:
vitamin K
hepatocellular carcinoma
anti-cancer drug
drug delivery
menaquinone-4
Online Access:http://www.mdpi.com/2079-9721/3/3/150

Internet

http://www.mdpi.com/2079-9721/3/3/150

Similar Items